What is the CVR number of MedTrace Pharma A/S?

MedTrace Pharma A/S is registered with CVR / Virk under CVR 36497661.

What is the revenue of MedTrace Pharma A/S?

MedTrace Pharma A/S reported revenue of DKK 2,3M in 2024.

MedTrace Pharma A/S employs 35 people as of the latest annual report.

Peter Juul Kristensen is the CEO of MedTrace Pharma A/S, in role since 2025.

Erik Anders Strömqvist chairs the board of MedTrace Pharma A/S, in role since 2024.

MedTrace Pharma A/S's registered address is Agern Alle 5A.

A/SActiveAdvertising protection

CVR 36497661Agern Alle 5A, 2970 HørsholmRental and leasing of other machinery, equipment and tangible goods n.e.c.· NACE 7739Est. 2015 · 11 years old35 employeeswww.medtrace.dk

Actively employed in the business

Name	Role	Member since
Current (3)
MD Martin Dal Stenfeldt Founder	Founder	2015
PJ Peter Juul Kristensen Chief Executive Officer	Chief Executive Officer	2025
LR Lykke Rømer Management	Management	2025
Former (4)
PL Peter Larsen Management	Management	2015 – 2015
RW Rune Wiik Kristensen Management	Management	2021 – 2024
LT Lars Trolle Management	Management	2024 – 2025
AK Ann Kristin Brøgger Led Chief Executive Officer	Chief Executive Officer	2024 – 2025

Non-executive oversight

Name	Role	Member since
Current (6)
CO Cesare Orlandi Board of Directors	Board of Directors	2020
ER Ellen Rietmann Ahl Board of Directors	Board of Directors	2026
JH Jens Hesthaven Sørensen Board of Directors	Board of Directors	2018
CH Claus Henrik Berner Møller Board of Directors	Board of Directors	2024
EA Erik Anders Strömqvist Chairman	Chairman	2024
CV Charlotte Vindfeldt Board of Directors	Board of Directors	2025
Former (7)
MS Mads Spangaard Rasmussen Board of Directors	Board of Directors	2015 – 2023
LM Lenna Maria Boe Broberg Board of Directors	Board of Directors	2016 – 2018
BS Bernt Skov Jensen Board of Directors	Board of Directors	2015 – 2021
BH Bjarne Henning Jensen Chairman	Chairman	2015 – 2017
RK Robert Karl Schier Board of Directors	Board of Directors	2021 – 2025
MF Michael Frank Board of Directors	Board of Directors	2018 – 2021
US Ulrik Spork Chairman	Chairman	2017 – 2021

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Arbejdsmarkedets Tillægspension	Company	33.33–49.99%	33.33–49.99%	2026
MedTravest IV ApS	Company	15–19.99%	15–19.99%	2026
Swisscanto Private Equity I KmGK	Individual	10–14.99%	10–14.99%	2023
Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I	Individual	5–9.99%	5–9.99%	2025
WASABI-LINK Holding ApS	Company	5–9.99%	5–9.99%	2021
Styrelsen for Forskning og Uddannelse	Company	20–24.99%	20–24.99%	2015
EIC Fund	Individual	5–9.99%	5–9.99%	2021
Uddannelses- og Forskningsstyrelsen	Company	5–9.99%	5–9.99%	2021
FONDEN FOR SYDDANSK VÆKSTFREMME	Company	5–9.99%	5–9.99%	2023
Kapitalforeningen BankInvest Select	Company	5–9.99%	5–9.99%	2025
MedTravest A/S	Company	5–9.99%	5–9.99%	2018

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.